期刊文献+

重症大疱性药疹免疫机制及免疫治疗进展 被引量:1

Immunopathogenesis and immunotherapy of severe bunons drug eruptions
原文传递
导出
摘要 重症大疱性药疹,包括重症多形红斑、Stevens-Johnson综合征、中毒性表皮坏死松解症,是皮肤科最严重的疾病之一。近年对其发病的免疫机制有新的认识,主要是在Fas-FasL介导的细胞凋亡、细胞毒T细胞的作用、肿瘤坏死因子-α诱导凋亡及线粒体的损伤方面。在临床治疗中可应用免疫治疗药物,如静脉滴注丙种球蛋白、环孢素、沙利度胺及抗肿瘤坏死因子单克隆抗体等。 Severe bullous drug eruption, including erythema multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis, are one of the most severe skin diseases. Some advances have been made in their immunopathogenesis, such as the apoptosis mediated by Fas-FasL and induced by TNF-α , effect of cytotoxic T cells, and mitochondrial damage. Furthermore, these diseases can be managed with immunotherapy, e.g. intravenous immunoglobulin, cyclosporine, thalidomide and anti-TNF monoclonal antibodies.
出处 《国际皮肤性病学杂志》 2008年第2期78-80,共3页 International Journal of Dermatology and Venereology
关键词 药疹 Stevens—Johnson综合征 表皮坏死松解症 中毒性 免疫疗法 Drug eruptions Stevens-Johnson syndrome Epidermal necrolysis, toxic Immunotherapy
  • 相关文献

参考文献17

  • 1Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science, 1998, 282( 5388 ): 490-493. 被引量:1
  • 2Abe R, Shimizu T, Shibaki A, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas lig-and. Am J Pathol, 2003, 162(5): 1515-1520. 被引量:1
  • 3ViardoLeveugle I, Bullani RR, Meda P, et al. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem, 2003, 278 (18): 16183-16188. 被引量:1
  • 4Nassif A, Moslehi H, Le Gouvello S, et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol, 2004, 123(5 ): 850-855. 被引量:1
  • 5Nassif A, Bensussan A, Boumsell L, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol, 2004, 114( 5 ): 1209-1215. 被引量:1
  • 6Posadas SJ, Padial A, Tortes MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol, 2002, 109( 1 ): 155-161. 被引量:1
  • 7Nassif A, Bensussan A, Doroth6 e G, et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol, 2002, 118(4): 728-733. 被引量:1
  • 8Chave TA, Mortimer NJ, Sladden MJ, et al. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol, 2005, 153(2): 241-253. 被引量:1
  • 9Paquet P, Pierard GE. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree bums. Int J Mol Med, 1998, 1(2): 459-462. 被引量:1
  • 10Lemer LH, Qureshi AA, Reddy BV, et al. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J Invest Dermatol, 2000, 114( 1 ): 196-199. 被引量:1

同被引文献14

  • 1Uehara R, Belay ED. Epidemiology of Kawasaki disease in asia, europe, and the united states. J Epidemiol, 2012,22 (2) :79-85. 被引量:1
  • 2Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005,47(2) :232-234. 被引量:1
  • 3Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovas- cular disease in the young, American Heart Association. Circulation, 2004,110 (17) :274-7-2771. 被引量:1
  • 4Straface E, Gambardella L, Metere A, et al. Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem Biophys Res Commun, 2010,392 ( 3 ) :426-430. 被引量:1
  • 5Tsujimoto H, Takeshita S, Nakatani K, et al. Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol, 2001,126(2) :355-364. 被引量:1
  • 6Galeotti C, Bayry J, Kone-Pant I, et al. Kawasaki disease : aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev, 2010,9(6) :441-448. 被引量:1
  • 7Tawfik DS, Cowan KR, Walsh AM, et al. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production. Pediatr Allergy Immunol, 2012,23 ( 1 ) :88-95. 被引量:1
  • 8von Gunten S, Simon HU. Cell death modulation by intravenous immunoglobulin. J Clin Immunol, 2010,30 Suppl 1 :S24-S30. 被引量:1
  • 9Tsujimoto H, Takeshita S, Nakatani K, et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol, 2002,103(2) :161-168. 被引量:1
  • 10狄亚珍,邱海燕,张建萍,康国贵,陈慧琴,张若松,李潮,冯意红,赵剑英.外周血淋巴细胞凋亡调控因子Fas/FasL和血清可溶性Fas与川崎病的相关性研究[J].中华风湿病学杂志,2008,12(9):635-637. 被引量:7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部